Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.

作者: Richard J. Pietras , David Gallardo , P. Nancy Wongvipat , H. Julie Lee , Joseph C. Poen

DOI:

关键词:

摘要: The management of human breast cancer frequently includes radiation therapy as an important intervention, and improvement in the clinical efficacy is desirable. Overexpression HER-2 growth factor receptor occurs 25–30% cancers correlates with poor outcome, including earlier local relapse following conservative surgery accompanied by therapy. In cells overexpression receptor, recombinant humanized monoclonal antibodies (rhuMAbs) to receptors (rhuMAb HER-2) decrease cell proliferation vitro reduce tumor formation nude mice. Therapy rhuMAb enhances sensitivity at doses 1–5 Gy, exceeding remission rates obtained alone. This benefit specific does not occur without overexpression. Treatment (2–4 Gy) alone provokes a marked increase unscheduled DNA synthesis, measure repair, but HER-2-overexpressing treated combination demonstrate synthesis 25–44% controls. Using alternate test i.e., radiation-damaged or undamaged reporter DNA, we introduced cytomegalovirus-driven β-galactosidase into that had been control. At 24 h posttransfection, extent repair assayed measuring expression was high after exposure significantly lower combined To further characterize effects antibody on growth, analyses cycle phase distribution were performed. Antibody reduces fraction S 48 h. Radiation treatment also known promote arrest, predominantly G1, low S-phase presence HER-2, elicits similar reduction h, significant reversal this arrest appears begin postradiation exposure. level greater than found antibody-radiation therapy, suggesting early escape from antireceptor may allow sufficient time for completion cells. Because it well failure adequate p21WAF1 induction damage associated assessed activity critical mediator cellular response damage. results show transcripts protein product 6, 12, treatment; however, increased levels transcript are sustained exposed HER-2. Although 6–12 they both diminished Levels antibody. A basal occurred 12–24 effect be related tyrosine phosphorylation protein. Tyrosine alone, blocked radiation. dysregulation independent p53 correlate reduced mdm2 These data indicate damaged especially vulnerable injury if deprived essential signal transduction pathways provided pathway.

参考文章(53)
J C Sarup, H M Shepard, B M Fendly, M T Lipari, K L King, A Ullrich, R M Johnson, M A Napier, Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth. Growth regulation. ,vol. 1, pp. 72- 82 ,(1991)
Fornace Aj, Zhan Q, Chen It, Smith Ml, O'Connor Pm, Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage Oncogene. ,vol. 10, pp. 1053- 1059 ,(1995)
M D Pegram, R J Pietras, S B Howell, V R Chazin, B M Fendly, D J Slamon, Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene. ,vol. 9, pp. 1829- 1838 ,(1994)
Gabriel Hortobagyi, Jae Y. Ro, Mark Blick, Debra Frye, Herbert Fritsche, Jungsil Ro, Adel K El-Naggar, Giuseooe Fraschini, c-erbB-2 Amplification in Node-negative Human Breast Cancer Cancer Research. ,vol. 49, pp. 6941- 6944 ,(1989)
Julie A. Lofgren, Brian M. Fendly, Andrew Nuijens, Gail D. Lewis, Mark X. Sliwkowski, Amy E. McMurtrey, Kenneth D. Bauer, Growth Regulation of Human Breast and Ovarian Tumor Cells by Heregulin: Evidence for the Requirement of ErbB2 as a Critical Component in Mediating Heregulin Responsiveness Cancer Research. ,vol. 56, pp. 1457- 1465 ,(1996)
Alexander Levitzki, Chun-Ming Tsai, Aviv Gazit, Chia-Chien Cheng, Li-Hwa Wu, Kuo-Ting Chang, Reury-Perng Perng, Enhancement of Chemosensitivity by Tyrphostin AG825 in High-p185neu Expressing Non-Small Cell Lung Cancer Cells Cancer Research. ,vol. 56, pp. 1068- 1074 ,(1996)
B A Gusterson, R D Gelber, A Goldhirsch, K N Price, J Säve-Söderborgh, R Anbazhagan, J Styles, C M Rudenstam, R Golouh, R Reed, Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. Journal of Clinical Oncology. ,vol. 10, pp. 1049- 1056 ,(1992) , 10.1200/JCO.1992.10.7.1049
Gary M. Williams, Detection of Chemical Carcinogens by Unscheduled DNA Synthesis in Rat Liver Primary Cell Cultures Cancer Research. ,vol. 37, pp. 1845- 1851 ,(1977)
Bert Vogelstein, David Sidransky, Ruth W. Craig, Michael B. Kastan, Onyinye Onyekwere, Participation of p53 Protein in the Cellular Response to DNA Damage Cancer Research. ,vol. 51, pp. 6304- 6311 ,(1991)
Nikki J. Holbrook, Jennifer L. Martindale, Myriam Gorospe, Yusen Liu, Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Research. ,vol. 56, pp. 31- 35 ,(1996)